Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Satsuma Pharmaceuticals, Inc. (STSA) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Satsuma Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1692830.
Total stock buying since 2019: $106,938,897.
Total stock sales since 2019: $2,705,055.
Total stock option exercises since 2019: $64,896.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 52,530,894 | $47,803,112 | 0 | $0 | 0 | $0 |
| 2022 | 6,590,000 | $4,501,329 | 3,250,000 | $2,294,500 | 0 | $0 |
| 2021 | 1,734,919 | $9,634,471 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 15,865 | $410,555 | 15,865 | $64,896 |
| 2019 | 2,999,999 | $44,999,985 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 52,530,894 | $47,803,112 | 0 | $0 | 0 | $0 |
| 2022-11 | 6,590,000 | $4,501,329 | 3,250,000 | $2,294,500 | 0 | $0 |
| 2021-11 | 52,329 | $300,575 | 0 | $0 | 0 | $0 |
| 2021-10 | 450,196 | $2,333,899 | 0 | $0 | 0 | $0 |
| 2021-02 | 1,232,394 | $6,999,997 | 0 | $0 | 0 | $0 |
| 2020-09 | 0 | $0 | 1,750 | $38,854 | 1,750 | $7,979 |
| 2020-08 | 0 | $0 | 2,000 | $47,986 | 2,000 | $9,120 |
| 2020-07 | 0 | $0 | 2,000 | $53,474 | 2,000 | $9,120 |
| 2020-06 | 0 | $0 | 4,115 | $125,092 | 4,115 | $11,319 |
| 2020-05 | 0 | $0 | 3,000 | $70,000 | 3,000 | $13,680 |
| 2020-04 | 0 | $0 | 1,000 | $20,049 | 1,000 | $4,558 |
| 2020-03 | 0 | $0 | 2,000 | $55,100 | 2,000 | $9,120 |
| 2019-09 | 2,999,999 | $44,999,985 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-08 | Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) | Buy | 8,423,732 | .91 | 7,665,596 |
| 2023-06-06 | Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) | Buy | 22,053,581 | .91 | 20,068,758 |
| 2023-06-06 | Takanashi Ken (Director) | Buy | 22,053,581 | .91 | 20,068,758 |
| 2022-11-21 | Leonard Braden Michael | Buy | 150,000 | .71 | 106,800 |
| 2022-11-15 | Leonard Braden Michael | Buy | 831,694 | .63 | 524,798 |
| 2022-11-14 | Commodore Capital Lp | Sale | 3,250,000 | .71 | 2,294,500 |
| 2022-11-14 | Leonard Braden Michael | Buy | 5,608,306 | .69 | 3,869,731 |
| 2021-11-24 | Commodore Capital Lp | Buy | 2,922 | 5.42 | 15,837 |
| 2021-11-22 | Commodore Capital Lp | Buy | 9,979 | 5.49 | 54,784 |
| 2021-11-19 | Commodore Capital Lp | Buy | 3,225 | 5.44 | 17,544 |
| 2021-11-11 | Commodore Capital Lp | Buy | 7,941 | 6.05 | 48,043 |
| 2021-11-10 | Commodore Capital Lp | Buy | 9,622 | 5.85 | 56,288 |
| 2021-11-08 | Commodore Capital Lp | Buy | 560 | 5.99 | 3,354 |
| 2021-11-05 | Commodore Capital Lp | Buy | 7,800 | 5.95 | 46,410 |
| 2021-11-04 | Commodore Capital Lp | Buy | 1,400 | 5.88 | 8,232 |
| 2021-11-02 | Commodore Capital Lp | Buy | 8,880 | 5.64 | 50,083 |
| 2021-10-29 | Commodore Capital Lp | Buy | 44,651 | 5.71 | 254,957 |
| 2021-10-28 | Commodore Capital Lp | Buy | 15,082 | 5.55 | 83,705 |
| 2021-10-27 | Commodore Capital Lp | Buy | 39,581 | 5.45 | 215,716 |
| 2021-10-22 | Commodore Capital Lp | Buy | 27,629 | 5.51 | 152,235 |
| 2021-10-21 | Commodore Capital Lp | Buy | 32,816 | 5.40 | 177,206 |
| 2021-10-20 | Commodore Capital Lp | Buy | 40,663 | 5.44 | 221,206 |
| 2021-10-19 | Commodore Capital Lp | Buy | 87,580 | 5.07 | 444,030 |
| 2021-10-18 | Commodore Capital Lp | Buy | 36,194 | 4.87 | 176,264 |
| 2021-10-15 | Commodore Capital Lp | Buy | 126,000 | 4.83 | 608,580 |
| 2021-02-26 | Shah Rajeev M. | Buy | 1,232,394 | 5.68 | 6,999,997 |
| 2020-09-01 | O'neil Thomas P. (Chief Financial Officer) | Sale | 750 | 22.19 | 16,644 |
| 2020-09-01 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 750 | 4.56 | 3,419 |
| 2020-09-01 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 22.21 | 22,210 |
| 2020-09-01 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-08-05 | O'neil Thomas P. (Chief Financial Officer) | Sale | 1,000 | 25.00 | 25,000 |
| 2020-08-05 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-08-03 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 22.99 | 22,986 |
| 2020-08-03 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-07-01 | O'neil Thomas P. (Chief Financial Officer) | Sale | 1,000 | 26.64 | 26,643 |
| 2020-07-01 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-07-01 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 26.83 | 26,831 |
| 2020-07-01 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-06-23 | O'neil Thomas P. (Chief Financial Officer) | Sale | 2,115 | 35.23 | 74,511 |
| 2020-06-23 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 2,115 | 1.04 | 2,199 |
| 2020-06-01 | O'neil Thomas P. (Chief Financial Officer) | Sale | 1,000 | 25.32 | 25,324 |
| 2020-06-01 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-06-01 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 25.26 | 25,257 |
| 2020-06-01 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-05-20 | O'neil Thomas P. (Chief Financial Officer) | Sale | 2,000 | 25.00 | 50,000 |
| 2020-05-20 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 2,000 | 4.56 | 9,120 |
| 2020-05-05 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 20.00 | 20,000 |
| 2020-05-05 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-04-14 | Albrecht Detlef (Chief Medical Officer) | Sale | 800 | 20.00 | 16,000 |
| 2020-04-14 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 800 | 4.56 | 3,647 |
| 2020-04-01 | Albrecht Detlef (Chief Medical Officer) | Sale | 200 | 20.25 | 4,049 |
| 2020-04-01 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 200 | 4.56 | 911 |
| 2020-03-11 | O'neil Thomas P. (Chief Financial Officer) | Sale | 1,000 | 27.68 | 27,678 |
| 2020-03-11 | O'neil Thomas P. (Chief Financial Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2020-03-11 | Albrecht Detlef (Chief Medical Officer) | Sale | 1,000 | 27.42 | 27,422 |
| 2020-03-11 | Albrecht Detlef (Chief Medical Officer) | Option Ex | 1,000 | 4.56 | 4,560 |
| 2019-09-17 | Takanashi Ken (Director) | Buy | 233,333 | 15.00 | 3,499,995 |
| 2019-09-17 | Shah Rajeev M. (Director) | Buy | 1,333,333 | 15.00 | 19,999,995 |
| 2019-09-17 | Kolchinsky Peter | Buy | 1,333,333 | 15.00 | 19,999,995 |
| 2019-09-17 | Coulter James G | Buy | 100,000 | 15.00 | 1,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of STSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Satsuma Pharmaceuticals, Inc. (symbol STSA, CIK number 1692830) see the Securities and Exchange Commission (SEC) website.